Skip to main content

Advertisement

ADVERTISEMENT

News

News
07/19/2022
Dr. Robert Drennan, electrophysiologist at Cardiovascular Institute of the South (CIS), is the first in Louisiana to use the Abbott Aveir™ VR Leadless Pacemaker to treat abnormal heart rhythm. The procedure took place in the catheterization...
Dr. Robert Drennan, electrophysiologist at Cardiovascular Institute of the South (CIS), is the first in Louisiana to use the Abbott Aveir™ VR Leadless Pacemaker to treat abnormal heart rhythm. The procedure took place in the catheterization...
Dr. Robert Drennan,...
07/19/2022
Vascular Disease Management
News
07/12/2022
Mount Sinai study is first to link cardiovascular risk to a specific form of age-related macular degeneration
Mount Sinai study is first to link cardiovascular risk to a specific form of age-related macular degeneration
Mount Sinai study is first to...
07/12/2022
Cath Lab Digest
News
07/05/2022
Effects on the heart due to infection with the novel coronavirus occur mainly in patients with comorbidities such as obesity, diabetes and hypertension. The International Journal of Cardiology published an article on these findings.
Effects on the heart due to infection with the novel coronavirus occur mainly in patients with comorbidities such as obesity, diabetes and hypertension. The International Journal of Cardiology published an article on these findings.
Effects on the heart due to...
07/05/2022
Cath Lab Digest

Advertisement

News
06/30/2022
Study Intends to Demonstrate that Ultrasound Allows for Precise Deployment and Positive Positioning of the MANTA® Vascular Closure Device
Study Intends to Demonstrate that Ultrasound Allows for Precise Deployment and Positive Positioning of the MANTA® Vascular Closure Device
Study Intends to Demonstrate...
06/30/2022
Cath Lab Digest
News
06/30/2022
UH among the first health systems in the U.S. to use faster acting, genetically engineered version of the clot-busting tPA drug
UH among the first health systems in the U.S. to use faster acting, genetically engineered version of the clot-busting tPA drug
UH among the first health...
06/30/2022
Cath Lab Digest
News
06/30/2022
First-of-its-kind metal-alloy scoring, cutting, and constraining structure (CS) device continues to elevate angioplasty treatment of chronic dialysis fistulas and grafts.
First-of-its-kind metal-alloy scoring, cutting, and constraining structure (CS) device continues to elevate angioplasty treatment of chronic dialysis fistulas and grafts.
First-of-its-kind metal-alloy...
06/30/2022
Vascular Disease Management

Advertisement

News
06/28/2022
Reflow Medical, Inc., a California-based medical device company, has completed enrollment in the DEEPER LIMUS clinical trial (NCT04162418) to evaluate the Temporary Spur Stent System.
Reflow Medical, Inc., a California-based medical device company, has completed enrollment in the DEEPER LIMUS clinical trial (NCT04162418) to evaluate the Temporary Spur Stent System.
Reflow Medical, Inc., a...
06/28/2022
Cath Lab Digest
News
06/27/2022
The American Heart Association presents Get With The Guidelines, Stroke Gold Plus award for proven dedication to ensuring all stroke patients have access to best practices and life-saving care.
The American Heart Association presents Get With The Guidelines, Stroke Gold Plus award for proven dedication to ensuring all stroke patients have access to best practices and life-saving care.
The American Heart Association...
06/27/2022
Vascular Disease Management
News
06/22/2022
Researchers at The Ohio State University Wexner Medical Center and College of Medicine have developed a novel drug molecule that targets T-cells causing inflammation in heart failure patients, stopping further progression of the disease.
Researchers at The Ohio State University Wexner Medical Center and College of Medicine have developed a novel drug molecule that targets T-cells causing inflammation in heart failure patients, stopping further progression of the disease.
Researchers at The Ohio State...
06/22/2022
Cath Lab Digest

Advertisement

News
06/20/2022
Dr. Ankur Lodha is the first interventional cardiologist at Cardiovascular Institute of the South (CIS) in Lafayette to treat carotid artery disease and prevent future strokes using an innovative procedure called TransCarotid Artery...
Dr. Ankur Lodha is the first interventional cardiologist at Cardiovascular Institute of the South (CIS) in Lafayette to treat carotid artery disease and prevent future strokes using an innovative procedure called TransCarotid Artery...
Dr. Ankur Lodha is the first...
06/20/2022
Vascular Disease Management

Advertisement